After approving oral Wegovy in December 2025, the FDA has now also approved Clinical trial data shows that participants taking Foundayo achieved meaningful weight loss compared with placebo, reinforcing its potential as an effective treatment option
Additional Trials The broader TRIUMPH program may include additional trials evaluating retatrutide in specific populations or for specific indications, such as MASLD/NASH, though detailed information about all planned studies has not been fully disclosed
FDA has indicated that unapproved GLP-1 drugs don't undergo FDA review for safety, effectiveness, or quality before marketing, and that compounded drugs should generally be used only when an FDA-approved drug can't meet a patient's needs
doi: 10.3390/genes12121992
2016 May 27;118(11):17031705
This equalizes the pressure and makes it much easier to draw the liquid out